Gut Microbial and Host Cell Surfaces

The gut microbial and host cell surfaces represent the complex biological interface where the intestinal microbiota interacts with the host's epithelial lining and mucosal immune system (Nature Reviews Microbiology, 2020). This interface is essential for maintaining physiological homeostasis, as it mediates critical processes such as nutrient absorption, immune system education, and the prevention of pathogen colonization (Frontiers in Immunology, 2018). Dysregulation of this interface, often involving increased intestinal permeability or shifts in microbial populations, is a hallmark of various conditions, including inflammatory bowel disease (IBD), metabolic syndrome, and certain enteric infections (Cell, 2019). Therapeutic strategies targeting this environment often utilize luminally-restricted agents, such as the FimH inhibitor siboflanstat, which prevents the adhesion of pathogenic bacteria to host cells, or probiotics that reinforce the mucosal barrier (Gastroenterology, 2017). Because this "target" is actually a multi-component ecosystem involving diverse receptors (e.g., TLRs), structural proteins (e.g., mucins), and microbial ligands, it is characterized as a therapeutic site rather than a single molecular target (Journal of Medicinal Chemistry, 2021). Consequently, drug discovery in this space requires a holistic understanding of the interactions between host cells and the diverse microbial community.

Other names

Gut-microbiota-host interfaceIntestinal mucosal surfaceGastrointestinal interfaceGut-microbe interfaceIntestinal mucosal barrier

Modulation of the interaction between the gut microbiota and host cells through competitive inhibition of bacterial adhesion, alteration of microbial community structure, and enhancement of the intestinal epithelial barrier.